Literature DB >> 11514663

Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.

E Pol1, I Björk.   

Abstract

Cystatin B is unique among cysteine proteinase inhibitors of the cystatin superfamily in having a free Cys in the N-terminal segment of the proteinase binding region. The importance of this residue for inhibition of target proteinases was assessed by studies of the affinity and kinetics of interaction of human and bovine wild-type cystatin B and the Cys 3-to-Ser mutants of the inhibitors with papain and cathepsins L, H, and B. The wild-type forms from the two species had about the same affinity for each proteinase, binding tightly to papain and cathepsin L and more weakly to cathepsins H and B. In general, these affinities were appreciably higher than those reported earlier, perhaps because of irreversible oxidation of Cys 3 in previous work. The Cys-to-Ser mutation resulted in weaker binding of cystatin B to all four proteinases examined, the effect varying with both the proteinase and the species variant of the inhibitor. The affinities of the human inhibitor for papain and cathepsin H were decreased by threefold to fourfold and that for cathepsin B by approximately 20-fold, whereas the reductions in the affinities of the bovine inhibitor for papain and cathepsins H and B were approximately 14-fold, approximately 10-fold and approximately 300-fold, respectively. The decreases in affinity for cathepsin L could not be properly quantified but were greater than threefold. Increased dissociation rate constants were responsible for the weaker binding of both mutants to papain. By contrast, the reduced affinities for cathepsins H and B were due to decreased association rate constants. Cys 3 of both human and bovine cystatin B is thus of appreciable importance for inhibition of cysteine proteinases, in particular cathepsin B.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514663      PMCID: PMC2253190          DOI: 10.1110/ps.11901

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  41 in total

1.  Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration By release of loop anchoring through mutation of his110.

Authors:  A Pavlova; J C Krupa; J S Mort; M Abrahamson; I Björk
Journal:  FEBS Lett       Date:  2000-12-29       Impact factor: 4.124

2.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

3.  Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.

Authors:  E Pol; I Björk
Journal:  Biochemistry       Date:  1999-08-10       Impact factor: 3.162

4.  Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.

Authors:  J Kos; M Krasovec; N Cimerman; H J Nielsen; I J Christensen; N Brünner
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

5.  Cystatin-like cysteine proteinase inhibitors from human liver.

Authors:  G D Green; A A Kembhavi; M E Davies; A J Barrett
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

6.  Interaction of the cysteine proteinase inhibitor chicken cystatin with papain.

Authors:  P Lindahl; E Alriksson; H Jörnvall; I Björk
Journal:  Biochemistry       Date:  1988-07-12       Impact factor: 3.162

7.  Three forms of thiol proteinase inhibitor from rat liver formed depending on the oxidation-reduction state of a sulfhydryl group.

Authors:  N Wakamatsu; E Kominami; K Takio; N Katunuma
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

8.  Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids.

Authors:  M Abrahamson; A J Barrett; G Salvesen; A Grubb
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

9.  Species variants of cathepsin L and their immunological identification.

Authors:  R W Mason
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

10.  The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases.

Authors:  W Bode; R Engh; D Musil; U Thiele; R Huber; A Karshikov; J Brzin; J Kos; V Turk
Journal:  EMBO J       Date:  1988-08       Impact factor: 11.598

View more
  7 in total

Review 1.  Cathepsin B as a cancer target.

Authors:  Christopher S Gondi; Jasti S Rao
Journal:  Expert Opin Ther Targets       Date:  2013-01-08       Impact factor: 6.902

2.  Transcriptomic analysis in the leech Theromyzon tessulatum: involvement of cystatin B in innate immunity.

Authors:  Christophe Lefebvre; Claude Cocquerelle; Franck Vandenbulcke; David Hot; Ludovic Huot; Yves Lemoine; Michel Salzet
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

3.  Transcriptome analyses of amoebic gill disease-affected Atlantic salmon (Salmo salar) tissues reveal localized host gene suppression.

Authors:  James W Wynne; Maree G O'Sullivan; Mathew T Cook; Glenn Stone; Barbara F Nowak; David R Lovell; Nicholas G Elliott
Journal:  Mar Biotechnol (NY)       Date:  2008-01-25       Impact factor: 3.619

4.  Steady-state and time-resolved fluorescence spectroscopic studies on interaction of the N-terminal region with the hairpin loop of the phytocystatin Scb.

Authors:  Keiko Doi-Kawano; Etsuko Nishimoto; Yoshiaki Kouzuma; Daisuke Takahashi; Shoji Yamashita; Makoto Kimura
Journal:  J Fluoresc       Date:  2008-12-23       Impact factor: 2.217

5.  Structural Dynamics Investigation of Human Family 1 & 2 Cystatin-Cathepsin L1 Interaction: A Comparison of Binding Modes.

Authors:  Suman Kumar Nandy; Alpana Seal
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

6.  Investigating Novel Genes Potentially Involved in Endometrial Adenocarcinoma using Next-Generation Sequencing and Bioinformatic Approaches.

Authors:  Feng-Hsiang Tang; Wei-An Chang; Eing-Mei Tsai; Ming-Ju Tsai; Po-Lin Kuo
Journal:  Int J Med Sci       Date:  2019-09-07       Impact factor: 3.738

7.  Antifungal activity of dendritic cell lysosomal proteins against Cryptococcus neoformans.

Authors:  Benjamin N Nelson; Savannah G Beakley; Sierra Posey; Brittney Conn; Emma Maritz; Janakiram Seshu; Karen L Wozniak
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.